https://www.selleckchem.com/pr....oducts/LDE225(NVP-LD
0 ± 2.4 days vs. 65-79 yo 2.2 ± 2.8 days vs. 80+ yo 2.3 ± 2.1 days, = 0.028), higher proportion of patients with extended LOS (50-64 yo18.3% vs. 65-79 yo21.9% vs. 80+ yo28.4%, = 0.009), and increased rates of non-routine discharges (50-64 yo15.1% vs. 65-79 yo23.0% vs. 80+ yo35.8%, 0.001). On multivariate analysis, age 80+ years was found to be a significant independent predictor of extended LOS [OR1.97, 95% CI(1.10,3.55), = 0.023] and non-routine discharge [OR2.46, 95% CI(1.44,4.21), = 0.001]. Our study demonstrates that